Advanced Care Provider and Nursing Approach to Assessment and Management of Immunotherapy-Related Dermatologic Adverse Events

Advanced care providers (ACPs) and nurses are fundamental players in the assessment and management of immunotherapy-related dermatologic adverse events (irdAE). Pembrolizumab, nivolumab, and ipilimumab are approved for unresectable or metastatic melanoma, metastatic non–small cell lung cancer (pembr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciccolini, Kathryn, Lucas, Anna Skripnik, Weinstein, Alyona, Lacouture, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995492/
https://www.ncbi.nlm.nih.gov/pubmed/29900022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995492/
https://www.ncbi.nlm.nih.gov/pubmed/29900022

Ejemplares similares